Regarding tumor type, high IDO1 expression was commonly seen in uterine cancer (54.2% of uterine tumors), followed by ovarian (37.2%), lung (25.0%), esophageal (17.6%), and breast cancer (16.3%) (Figure 1). This evidence concerns the gene IDO1 and breast carcinoma.